Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Ventricular Access Devices Are Safe and Effective in the Treatment of Posthemorrhagic Ventricular Dilatation prior to Shunt Placement

Tian A.G.a, b · Hintz S.R.c · Cohen R.S.c · Edwards M.S.B.a, b

Author affiliations

Departments of aNeurosurgery, bPediatric Neurosurgery and Pediatrics and cNeonatology, Lucile Salter Packard Children’s Hospital, Stanford University, Stanford, Calif., USA

Related Articles for ""

Pediatr Neurosurg 2012;48:13–20

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 21, 2011
Accepted: March 02, 2012
Published online: July 21, 2012
Issue release date: October 2012

Number of Print Pages: 8
Number of Figures: 6
Number of Tables: 0

ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)

For additional information: https://www.karger.com/PNE

Abstract

Intraventricular hemorrhage of prematurity (IVH) is a diagnosis that has become more frequent in recent years. Advances in medical care have led to survival of increasingly premature infants, as well as infants with more complex medical conditions. Treatment with a ventricular access device (VAD) was reported almost 3 decades ago; however, it is unclear how effective this treatment is in the current population of premature infants. At our institution (from 2004 to present), we treat posthemorrhagic hydrocephalus (PHH) with a VAD. In order to look at safety and efficacy, we retrospectively combed the medical records of premature children, admitted to Lucile Packard Children’s Hospital from January 2005 to December 2009, and identified 310 premature children with IVH. Of these, 28 children required treatment for PHH with a VAD. There were no infections associated with placement of these devices and a very low rate of other complications, such as need for repositioning (7.41%) or replacement (3.75%). Our data show that treatment with a VAD is very safe, with few complications and can be used to treat PHH in this very complex infant population.

© 2012 S. Karger AG, Basel


References

  1. Hamilton BE, Martin JA, Ventura SJ: Births; preliminary data for 2007. Natl Vital Stat Rep 2009;57:1–23.
  2. Papile LA, Burnstein J, Burnstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529–534.
  3. Volpe JJ: Neonatal intraventricular hemorrhage. N Engl J Med 1981;304:886–891.
  4. Limbrick DD Jr, Mathur A, Johnston JM, Munro R, Sagar J, Inder T, Park TS, Leonard JL, Smyth MD: Neurosurgical treatment of progressive posthemorrhagic ventricular dilation in preterm infants: a 10-year single-institution study. J Neurosurg Pediatr 2010;6:224–230.
    External Resources
  5. Berger A, Weninger M, Reinprecht A, Hascke N, Kohlhauser C, Pollack A: Long-term experience with subcutaneously tunneled catheters external ventricular drainage in preterm infants. Childs Nerv Syst 2000;16:103–110.
  6. Gaskill SJ, Marlin AE, Rivera S: The subcutaneous ventricular reservoir: an effective treatment for posthemorrhagic hydrocephalus. Childs Nerv Syst 1988;4:291–295.
  7. Kazan S, Gura A, Ucar T, Korkmaz E, Ongun H, Akyuz M: Hydrocephalus after intraventricular hemorrhage in preterm and low-birth weight infants: analysis of associated risk factors for peritoneal shunting. Surg Neurol 2005;64(suppl 2):S77–S81.
  8. McComb JG, Ramos AD, Platzker ACG, Henderson DJ, Segall HD: Management of hydrocephalus secondary to intraventricular hemorrhage in the preterm infant with a subcutaneous ventricular catheter reservoir. Neurosurgery 1983;13:295–300.
  9. Peretta P, Ragazzi P, Carlino CF, Gaglini P, Cinalli G: The role of Ommaya reservoir and endoscopic third ventriculostomy in the management of post-hemorrhagic hydrocephalus of prematurity. Childs Nerv Syst 2007;23:765–771.
  10. Whitelaw A, Rivers RP, Creighton L, Gaffney P: Low dose intraventricular fibrinolytic treatment to prevent post-hemorrhagic hydrocephalus. Arch Dis Child 1992;67:12–14.
  11. Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N: A phase I study of intraventricular recombinant tissue plasminogen activator for the treatment of post-hemorrhagic hydrocephalus. Arch Dis Child 1996;75:F20–F26.
  12. Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N: Intraventricular hemorrhage and post-hemorrhagic hydrocephalus: pathogenesis, prevention and future interventions. Semin Neonatol 2001;6:135–146.
  13. Yu B, Li, Lin Z, Zhang N: Treatment of posthemorrhagic hydrocephalus in premature infants with subcutaneous reservoir drainage. Pediatr Neurosurg 2009;45:119–125.
  14. Bradley JS, Wassel RT, Lee L, Nambiar S: Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics 2009;123:e609–e613.
    External Resources
  15. Mohamed MA, Aly H: Male gender is associated with intraventricular hemorrhage. Pediatrics 2010;125:e333–e339.
    External Resources
  16. Stevenson DK, Verter J, Fanaroff AA, Oh W, Ehrenkranz RA, Shankaran S, Donovan EF, Wright LL, Lemons JA, Tyson JE, Korones SB, Bauer CR, Stoll BJ, Papile LA: Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed 2000;83:F182–F185.
  17. Kormanik K, Praca J, Garton HJ, Sarkar S: Repeated tapping of ventricular reservoir in preterm infants with post-hemorrhagic ventricular dilatation does not increase the risk of reservoir infection. J Perinatol 2010;30:218–221.
  18. Richard E, Cinalli G, Assis D, Pierre-Kahn A, Lacaze-Masmonteil T: Treatment of post-haemorrhage ventricular dilatation with an Ommaya’s reservoir: management and outcome of 64 preterm infants. Childs Nerv Syst 2001;17:334–340.
  19. Willis B, Javalkar V, Vannemreddy P, Caldito G, Matsuyama J, Guthikonda B, Bollam P, Nanda A: Ventricular reservoirs and ventriculoperitoneal shunts for premature infants with posthemorrhagic hydrocephalus: an institutional experience. J Neurosurg Pediatr 2009;3:94–100.
    External Resources
  20. Koksal V, Oktem S: Ventriculosubgaleal shunt procedure and its long-term outcomes in premature infants with post-hemorrhagic hydrocephalus. Childs Nerv Syst 2010;26:1505–1515.
    External Resources
  21. Tubbs RS, Banks JT, Soleau S, Smyth MD, Wellons JC, 3rd, Blount JP, Grabb PA, Oakes WJ: Complications of ventriculosubgaleal shunts in infants and children. Childs Nerv Syst 2005;21:48–51.
  22. Willis BK, Kumar CR, Wylen EL, Nanda A: Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants. Pediatr Neurosurg 2005;41:178–185.
  23. Lam HP, Heilman CB: Ventricular access device versus ventriculosubgaleal shunt in post hemorrhagic hydrocephalus associated with prematurity. J Matern Fetal Neonatal Med 2009;22:1097–1101.
    External Resources
  24. Massone ML, Cama A, Puccio VF, Montobbio G, Soliani M, Andreussi L, Fossa S: Management of post-hemorrhagic ventricular dilation in premature infants with long-term external ventricular drainage. Eur J Pediatr Surg 1993;3(suppl 1):22–23.
    External Resources
  25. Kreusser KL, Tarby TJ, Taylor D, Kovnar E, Hill A, Conry JA, Volpe JJ: Rapidly progressive posthemorrhagic hydrocephalus. Treatment with external ventricular drainage. Am J Dis Child 1984;138:633–637.
  26. Cherian S, Whitelaw A, Thoresen M, Love S: The pathogenesis of neonatal post-hemorrhagic hydrocephalus. Brain Pathol 2004;14:305–311.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 21, 2011
Accepted: March 02, 2012
Published online: July 21, 2012
Issue release date: October 2012

Number of Print Pages: 8
Number of Figures: 6
Number of Tables: 0

ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)

For additional information: https://www.karger.com/PNE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.